GlaxoSmithKline S.A in Tres Cantos, Spain, is a GlaxoSmithKline (GSK) Local Operating Company dedicated since 2001 to the development and commercialization of new medicines, vaccines and Consumer Healthcare products. Within GSK S.A. the Clinical Research Area is responsible for the set up and conduct of clinical research programs activities. These activities range from identifying investigational sites, preparation of clinical trials and Epidemiologic documentation for Competent Authorities and Ethical Review Boards (including development of informed consent forms), monitoring the study conduct and publication of results.
Role in the project
GSK will contribute providing the Industry Sponsor point of view in Clinical Research. Pharmaceutical Industry accounts for a large percentage of the clinical trials conducted in EU and therefore the private pharmaceutical experiencie and perspective can help to better understand the current situation and to facilitate adoption of the new guidelines resulting of this project in the future. As an Innovative Industry looking for new treatments, GSK SA works in partnership with Health Institutions, Physicians, nurses, RECs and Authorities to develop new drugs and vaccines to cover unmet medical and public health needs. GSK will take part in all the project WPs with its highest dedication in WP3.
Mrs. Olga Maria Martinez-Casares
Olga Maria Martinez-Casares is head of clinical research strategy, clinical development early phases, and patient advocacy in the Medical Department of GSK.
She has a degree in Pharmacy and a Master degree in Direction and Management of Research, Development and Innovation in Health Sciences.
She has a long experience both in technical and managerial positions in clinical research, including team and matrix leadership in local and international teams.
REYES BOCETA MUÑOZ
ELENA LOPEZ SANTOS
FRANCISCO JAVIER RUBIO POMAR
MARIA CUBILLO DIAZ-VALDES